| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |